Data compiled here suggest that giant cell glioblastomas and oligodendrogliomas are overrepresented, cutaneous anomalies, such as café-au-lait macules and pilomatricomas, may serve as clinical markers, and that surveillance colonoscopy is warranted in brain tumor patients carrying POLE/POLD1 germline variants. This evidence concerns the gene POLE and oligodendroglioma.